Eisai’s revved-up Belviq marketing starting to pay off, analysts say

Carly Helfand

When it comes to addressing the market, pharma has three P's, according to Eisai's Michael O'Brien: physician, payer and patient. And as VP of specialty , O'Brien is looking to hit each of them in promoting the recently launched weight-loss drug .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS